AliveDx Expands Autoimmune Menu with IVDR-CE Marked MosaiQ AiPlex® CTDplus Multiplex Assay to Aid in Diagnosing Systemic Autoimmune Rheumatic Diseases and Streamline Laboratory Workflow

Contributed by: PR Newswire

Tags

AliveDx

More Like This

AliveDx receives three IVDR CE marks for its Multiplexed Autoimmune Diagnostics Solution

AliveDx Receives IVDR-CE Mark for Multiplexed Assay to Accurately Detect Celiac Disease (CD) on the MosaiQ® System

AliveDx announces US FDA 510(k) submission for MosaiQ AiPlex® Celiac Disease (CD) multiplex microarray

AliveDx Receives IVDR CE Mark for Groundbreaking Microarray Immunoassay in Allergy Diagnostics

AliveDx Announces Turnkey Solution for Precise, Automated Autoimmune Diagnostics

AliveDx receives IVDR Certification of its Manufacturing Sites in Switzerland and United Kingdom

PR Newswire associated0

Werfen Receives CE Mark for Aptiva® Antiphospholipid Syndrome Reagents

PR Newswire associated0

Seegene Showcased its Multiplex Technology at ADLM 2024